149 related articles for article (PubMed ID: 37454822)
1. Clinical features of pediatric Danon disease and the importance of early diagnosis.
Gandaeva L; Sonicheva-Paterson N; McKenna WJ; Savostyanov K; Myasnikov R; Pushkov A; Zhanin I; Barskiy V; Zharova O; Silnova I; Kaverina V; Sdvigova N; Fisenko A; Arad M; Basargina E
Int J Cardiol; 2023 Oct; 389():131189. PubMed ID: 37454822
[TBL] [Abstract][Full Text] [Related]
2. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene.
Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S
Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience.
Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report.
Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M
BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794
[TBL] [Abstract][Full Text] [Related]
5. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
[TBL] [Abstract][Full Text] [Related]
6. Danon disease as a cause of concentric left ventricular hypertrophy in patients who underwent endomyocardial biopsy.
Cheng Z; Cui Q; Tian Z; Xie H; Chen L; Fang L; Zhu K; Fang Q
Eur Heart J; 2012 Mar; 33(5):649-56. PubMed ID: 22108829
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical characteristics of Danon disease among patients with left ventricular hypertrophy and concomitant electrocardiographic preexcitation.
Liu Y; Chen X; Wang F; Liang Y; Deng H; Liao H; Zhang Q; Zhang B; Zhan X; Fang X; Shehata M; Wang X; Xue Y; Wu S
Mol Genet Genomic Med; 2019 May; 7(5):e638. PubMed ID: 30929317
[TBL] [Abstract][Full Text] [Related]
8. A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene.
Zhang Y; Ren H; Zhou S
Medicine (Baltimore); 2020 Oct; 99(40):e22640. PubMed ID: 33019488
[TBL] [Abstract][Full Text] [Related]
9. A novel LAMP2 mutation associated with severe cardiac hypertrophy and microvascular remodeling in a female with Danon disease: a case report and literature review.
Bottillo I; Giordano C; Cerbelli B; D'Angelantonio D; Lipari M; Polidori T; Majore S; Bertini E; D'Amico A; Giannarelli D; De Bernardo C; Masuelli L; Musumeci F; Avella A; Re F; Zachara E; d'Amati G; Grammatico P
Cardiovasc Pathol; 2016; 25(5):423-31. PubMed ID: 27497751
[TBL] [Abstract][Full Text] [Related]
10. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry.
López-Sainz Á; Salazar-Mendiguchía J; García-Álvarez A; Campuzano Larrea O; López-Garrido MÁ; García-Guereta L; Fuentes Cañamero ME; Climent Payá V; Peña-Peña ML; Zorio-Grima E; Jordá-Burgos P; Díez-López C; Brugada R; García-Pinilla JM; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):479-486. PubMed ID: 30108015
[TBL] [Abstract][Full Text] [Related]
11. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy.
Xu J; Wang L; Liu X; Dai Q
Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081
[TBL] [Abstract][Full Text] [Related]
12. Identification of Two Novel LAMP2 Gene Mutations in Danon Disease.
Csányi B; Popoiu A; Hategan L; Hegedűs Z; Nagy V; Rácz K; Hőgye M; Sághy L; Iványi B; Csanády M; Forster T; Sepp R
Can J Cardiol; 2016 Nov; 32(11):1355.e23-1355.e30. PubMed ID: 27179547
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.
Maron BJ; Roberts WC; Arad M; Haas TS; Spirito P; Wright GB; Almquist AK; Baffa JM; Saul JP; Ho CY; Seidman J; Seidman CE
JAMA; 2009 Mar; 301(12):1253-9. PubMed ID: 19318653
[TBL] [Abstract][Full Text] [Related]
14. Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study.
Gurka J; Piherova L; Majer F; Chaloupka A; Zakova D; Pelak O; Krebsova A; Peichl P; Krejci J; Freiberger T; Melenovsky V; Kautzner J; Kalina T; Sikora J; Kubanek M
ESC Heart Fail; 2020 Oct; 7(5):2534-2543. PubMed ID: 32657043
[TBL] [Abstract][Full Text] [Related]
15. Danon disease: a case report and literature review.
Xu J; Li Z; Liu Y; Zhang X; Niu F; Zheng H; Wang L; Kang L; Wang K; Xu B
Diagn Pathol; 2021 May; 16(1):39. PubMed ID: 33933120
[TBL] [Abstract][Full Text] [Related]
16. LAMP2 exon-copy number variations in Danon disease heterozygote female probands: Infrequent or underdetected?
Majer F; Piherova L; Reboun M; Stara V; Pelak O; Norambuena P; Stranecky V; Krebsova A; Vlaskova H; Dvorakova L; Kmoch S; Kalina T; Kubanek M; Sikora J
Am J Med Genet A; 2018 Nov; 176(11):2430-2434. PubMed ID: 30194816
[TBL] [Abstract][Full Text] [Related]
17. Alu-mediated Xq24 deletion encompassing CUL4B, LAMP2, ATP1B4, TMEM255A, and ZBTB33 genes causes Danon disease in a female patient.
Majer F; Kousal B; Dusek P; Piherova L; Reboun M; Mihalova R; Gurka J; Krebsova A; Vlaskova H; Dvorakova L; Krihova J; Liskova P; Kmoch S; Kalina T; Kubanek M; Sikora J
Am J Med Genet A; 2020 Jan; 182(1):219-223. PubMed ID: 31729179
[TBL] [Abstract][Full Text] [Related]
18. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children.
Yang Z; McMahon CJ; Smith LR; Bersola J; Adesina AM; Breinholt JP; Kearney DL; Dreyer WJ; Denfield SW; Price JF; Grenier M; Kertesz NJ; Clunie SK; Fernbach SD; Southern JF; Berger S; Towbin JA; Bowles KR; Bowles NE
Circulation; 2005 Sep; 112(11):1612-7. PubMed ID: 16144992
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics of Danon disease].
Wang WW; Zhu YY; Wu W; Zhao DC; Lin X; Fang LG; Zhang SY
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):51-57. PubMed ID: 36655242
[No Abstract] [Full Text] [Related]
20. International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
Hong KN; Eshraghian EA; Arad M; Argirò A; Brambatti M; Bui Q; Caspi O; de Frutos F; Greenberg B; Ho CY; Kaski JP; Olivotto I; Taylor MRG; Yesso A; Garcia-Pavia P; Adler ED
J Am Coll Cardiol; 2023 Oct; 82(16):1628-1647. PubMed ID: 37821174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
